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INTRODUCTION
In September 2015, the Council of the European Union adopted Council conclusions on the 
implementation of minimum quality standards in drug demand reduction in the EU. This innovative 
initiative lists 16 standards that represent a minimum benchmark of quality for interventions in: prevention, 
risk and harm reduction, treatment, social integration and rehabilitation. Although non-binding for national 
governments, this document represents the political will of EU countries to address demand reduction 
interventions through an evidence-based perspective. These guidelines have been drawn up in the context 
of Action 9 of the EU action plan on drugs (2013–2016).
In 2014, the Civil Society Forum on Drugs (CSFD) prepared and published the thematic paper on the 
EU minimum quality standards for drug demand reduction. The paper presents the context in which 
the EU Member States as well as candidate and potential candidate countries for EU membership are 
recommended to promote and enforce the minimum quality standards in drug demand reduction and 
provides a brief overview of associated issues and opportunities for consideration (including assessment 
and evaluation of the implementation of standards).
Since then, the CSFD has operated a working group on minimum quality standards, and the work of 
this group is enhanced by the CSFD project, co-funded by the European Commission under the Justice 
Programme (Drug Policy Initiatives). Work under this aspect of the project is led by the Institute »Utrip« from 
Slovenia (www.institut-utrip.si) and IREFREA Spain (www.irefrea.eu), and is carried out with the input of 
the members of the working group of the CSFD and with the broader CSFD membership. Objectives under 
the project in this area are as follows:
1.TO PROMOTE THE IMPLEMENTATION OF MINIMUM QUALITY 
STANDARDS IN EU MEMBER STATES (ADVOCACY), AND,
 
2.TO IMPROVE KNOWLEDGE AND SKILLS AMONG CSOs ON HOW TO 
IMPLEMENT MINIMUM QUALITY STANDARDS ON THE NATIONAL LEVEL. 
TO FACILITATE THIS, WORK UNDER THIS WORK PACKAGE HAS:
1. Developed an assessment tool to allow CSOs to monitor and assess implementation of minimum quality 
standards in their own countries and organizations. The initial 16 drug demand reduction standards have 
been broken down into 52 sub-standards,  64 questions and 222 assessment indicators (excluding non-
defined indicators, e.g. other). The online tool works as a self-assessment tool with automatic feedback of 
results (using traffic light system rating).
2. Developed a method of examining the feasibility of implementation of minimum quality standards among 
CSOs. The feasibility tool was incorporated in assessment tool and includes additional 52 questions and 144 
feasibility indicators.
During the process of tool testing, we received more than 100 inputs from diverse CSOs across Europe 
representing different areas of work (prevention, risk and harm reduction, social integration, rehabilitation 
and recovery). However, following data review, only 46 of them were selected as eligible for further analysis 
and inclusion in the written feasibility study. 
The assessment tool is available at the following link:
http://self-assessment.institut-utrip.si/index.php/71231?lang=en 
The feasibility study is available on the CSFD website at:
http://www.civilsocietyforumondrugs.eu/tf4-working-group-on-quality-standards-in-drug-policy/ 
Building on the insights gained from the assessment tool and feasibility study, the CSFD has now developed 
this guidelines and recommendations document. The aims of these guidelines and recommendations are to 
help and support CSOs working in the drug demand reduction field to:
1. assess and implement their interventions according to these standards
2. identify potential barriers for incorporation; and
3. assess the potential need to provide training for practitioners and developers in the drug demand 
reduction field in line with these standards
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TERMINOLOGY AND DEFINITIONS
Terminology can differ across languages and locations. To help with ensuring consistency in understanding 
the guidelines and recommendations, we use the following definitions:
PREVENTION
A prevention intervention promotes activities to prevent substance use behaviour. The goal is to reduce 
risk factors and enhance protective factors. Prevention is achieved through the application of multiple 
strategies; can be realised in different settings and with different methods and contents. The duration can 
vary between one-off activities and long-term projects. Prevention interventions are commonly classified in 
four categories: environmental, universal, selective and indicated interventions.
Environmental prevention strategies aim to change the cultural, social, physical and economic 
environments and include measures such as alcohol pricing and bans on tobacco advertising and smoking, 
for which there is good evidence of effectiveness. Universal prevention targets the whole population, 
while selective prevention targets (vulnerable) groups, both with the aim of deterring or delaying the 
onset of substance use. Indicated prevention acts at the individual level to: prevent the development of 
a dependence; to stop progression, diminish the frequency; and consequently to prevent substance use. 
(Adapted from EMCDDA Best Practice Portal)
RISK AND HARM REDUCTION
Risk and harm reduction encompasses interventions, programmes and policies that seek to reduce the 
health, social and economic harms of drug use to individuals, communities and societies. Risk and harm 
reduction is considered as a combination intervention, made up of a package of interventions tailored to 
local setting and need, which give primary emphasis to reducing the harms of drug use. (Adapted from 
EMCDDA monograph, 2010)
TREATMENT, SOCIAL INTEGRATION, REHABILITATION (INCLUDING RECOVERY)
Treatment, social integration, rehabilitation and recovery is defined as a set of activities that directly target 
people who have problems with their substance use and that aims at achieving defined goals with regard to 
the alleviation and/or elimination of these problems, provided by experienced and accredited professionals, 
in the framework of recognized medical, psychological or social assistance practice. (Adapted from EMCDDA 
Treatment Demand Indicator Protocol)
FORMAL EDUCATION AND/OR TRAINING
Education and training typically provided by an education or training institution, structured (in terms 
of learning objectives, learning time or learning support) and leading to certification. Formal learning is 
intentional from the learner’s perspective. (Definition by UNESCO)
NON-FORMAL EDUCATION AND/OR TRAINING 
Education and training which takes place outside the formal system either on a regular or intermittent basis. 
(Definition by UNESCO)
INFORMAL EDUCATION AND/OR TRAINING
Learning resulting from daily life activities related to work, family or leisure. Informal learning is part of 
non-formal learning. It is often referred to as experience based learning and can to a certain degree be 
understood as accidental learning. (Definition by UNESCO)
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WIDELY ACCESSIBLE SERVICES (ESPECIALLY RISK AND HARM REDUCTION SERVICES)
Widely accessible service is one, which can be accessed by a large majority of the people that need it in a 
jurisdiction.
NON-EXCLUSION POLICY
A non-exclusion policy means that service users (e.g. people who use/inject drugs) are not excluded or 
rejected in any way from services they need. Some services might have limitations (e.g. age, gender, status), 
but there should be services available which are tailored to the needs of any target population.
REASONABLE TIME (IN TREATMENT, SOCIAL REINTEGRATION, REHABILITATION AND RECOVERY)
In case of a crisis attendance for substitution treatment, intervention has to be available immediately and 
to be continued until necessary legal procedures (depending on legal situation of the country) are fulfilled 
for long-term substitution treatment. Residential non-abstinence rehabilitation treatment (combined 
with substitution treatment) should be available after a maximum of two weeks preparation phase. Detox 
treatment followed by abstinence oriented rehabilitation treatment should be available after a maximum 
of two weeks preparation phase with immediate admission after detox phase. Relapse (crisis intervention) 
treatment after a successful recovery intervention has to be available immediately. If the issue includes 
minors or persons at risk for their life, all services should be available without any delay (immediately).
HOW TO USE THESE GUIDELINES
For each of the 16 standards in the Council Conclusions, these guidelines provide:
• A copy of the text of the standard
• An insight into what the utilisation of the assessment tool by CSOs has told us about this standard
• An insight into what the feasibility analysis has told us about this standard
• Based on the insights above, (a) recommendation(s) to CSOs, highlighting key issues that may be of use 
as they work on implementing the standards
The guidelines can be used in conjunction with the assessment tool, the feasibility study and other relevant 
resources as supports to CSOs working on standards implementation.  
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PREVENTION
STANDARD 1: PREVENTION (ENVIRONMENTAL, UNIVERSAL, SELECTIVE AND INDICATIVE) 
INTERVENTIONS ARE TARGETED AT THE GENERAL POPULATION, AT POPULATIONS AT RISK 
OF DEVELOPING A SUBSTANCE USE PROBLEM OR AT POPULATIONS/INDIVIDUALS WITH AN 
IDENTIFIED PROBLEM. THEY CAN BE AIMED AT PREVENTING, DELAYING OR REDUCING DRUG 
USE, ITS ESCALATION AND/OR ITS NEGATIVE CONSEQUENCES IN THE GENERAL POPULATION 
AND/OR SUBPOPULATIONS; AND ARE BASED ON AN ASSESSMENT OF AND TAILORED TO THE 
NEEDS OF THE TARGET POPULATION.
 1.1. 
According to the assessment, this standard appears to be well implemented in participating EU Member 
States. The contemporary classification of prevention (four types of approaches) is widely used in policy 
documents (e.g. drug strategies and action plans) across Europe. In general, the aims mentioned in the 
standards are typically included in strategies and action plans at a general population level, but not 
necessarily for subpopulations. Mostly national data sources are available for assessment of the target 
population. However, involvement of the target population in needs assessment in all phases, especially 
during intervention design and evaluation (both process and outcome) remains a challenge.
 1.2.
According to the feasibility study, this standard is well implemented in CSOs, with universal and selective 
approaches widely used in their interventions and strategies. Mostly national and own data sources are 
used during the needs assessment. The needs of the target population are well assessed during all phases 
(intervention design, implementation and evaluation (both process and outcome).
 1.3.
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Ensure that target populations are involved in all phases of the needs assessment, and in intervention 
design and evaluation.
• Consequently, for CSOs working with a particular target group, it makes sense to focus only on this 
group, meaning selective and indicated prevention interventions targeted at a specific subpopulation 
are likely to be the main focus.
• Have defined in advance how you will collect, analyse and manage the data on these types of 
interventions. It will be of value not only to your own analysis and evaluation, but also to further 
development of regional and local data and for data on subpopulations. 
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STANDARD 2: THOSE DEVELOPING PREVENTION INTERVENTIONS HAVE COMPETENCIES 
AND EXPERTISE ON PREVENTION PRINCIPLES, THEORIES AND PRACTICE, AND ARE TRAINED 
AND/OR SPECIALISED PROFESSIONALS WHO HAVE THE SUPPORT OF PUBLIC INSTITUTIONS 
(EDUCATION, HEALTH AND SOCIAL SERVICES) OR WORK FOR ACCREDITED OR RECOGNISED 
INSTITUTIONS OR NGOS.
 2.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Specific competencies and expertise are rarely required for prevention workforce and governments or 
authorities very rarely officially accredit CSOs to work in prevention. There is almost no formal education 
and/or training available for prevention workforce. The situation is slightly better regarding non-formal and 
informal education and/or training. However, there is almost no support and funding for education and/
or training of the staff in the field of prevention by public institutions, especially at regional and local level. 
Staff do not tend to be recognised as prevention professionals at national, regional or local level.
 2.2. 
According to the feasibility study, this standard is not well implemented either in participating EU 
Member States. CSOs in the field of prevention mostly require university degree in a relevant area and 




For those CSOs interested in working on this standard, some things to consider are:
• Explore options to work with national or local authorities to work towards ensuring this standard is 
better implemented and that those who are committed to prevention work are trained and supported 
to do so. Given its status as a council conclusion, governments and authorities in EU Member States 
should be interested in exploring how work in this area can best be supported, for example by 
accrediting and recognising CSOs to work in the field of prevention and by providing support and 
sustainable funding for education and training, which could significantly improve competencies and 
expertise in this area of work.
• Before implementing or designing any prevention projects yourself, ensure that the staff who have been 
designated to carry out the work are properly supported and equipped, and have the competencies and 
expertise necessary to do the job. 
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STANDARD 3: THOSE IMPLEMENTING PREVENTION INTERVENTIONS HAVE ACCESS TO AND 
RELY ON AVAILABLE EVIDENCE-BASED PROGRAMMES AND/OR QUALITY CRITERIA AVAILABLE 
AT LOCAL, NATIONAL AND INTERNATIONAL LEVELS.
 3.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. There 
are almost no registries of evidence-based interventions available at national, regional and/or local level. 
While there are existing internationally recognised evidence-based intervention (EBI) registries (such as the 
Xchange registry by EMCDDA, Healthy Nightlife Toolbox (HNT) registry, Blueprints Programs registry and 
SAMHSA Evidence-based Practice registry), these are very rarely used by prevention professionals. There 
are some standards and/or guidelines available (mostly at national level) in some EU Member States, but use 
of these is not always mandatory for funding support.
 3.2. 
According to the feasibility study, this standard is also poorly implemented by participating CSOs. Existing 
international and/or national EBI registries are rarely used by CSOs in the field of prevention. In most of the 
cases, prevention professionals use national standards and/or guidelines (if they exist).
 3.3. 
Recommendation(s):
For those CSOs interested in working on this standard, some things to consider are:
• Make sure it is part of your internal processes when designing and implementing prevention 
interventions that existing internationally recognised and national EBI registries are taken into account, 
so prevention professionals use them on regular basis while developing, adapting, transferring and 
evaluating best practices in their environments and settings. 
• Ensure that it is part of induction and training for staff working on prevention interventions to receive 
input on how to use existing registries. 
• Explore the possibility of working with local, regional or national authorities to ensure that funding for 
interventions in this area requires those seeking it to show how the proposed intervention is consistent 
with the good practices on registries such as Xchange.
Guidelines and Recommendations for the implementation of Minimum Quality Standards in drug demand reduction in the European Union by Civil Society Organisations (CSOs)
10 // 26
STANDARD 4: PREVENTION INTERVENTIONS FORM PART OF A COHERENT LONG-TERM 
PREVENTION PLAN, ARE APPROPRIATELY MONITORED ON AN ONGOING BASIS ALLOWING 
FOR NECESSARY ADJUSTMENTS, ARE EVALUATED AND THE RESULTS DISSEMINATED SO AS TO 
LEARN FROM NEW EXPERIENCES.
 4.1.  
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Interventions are rarely implemented based on priorities in the national, regional or local level and there 
is almost no long-term sustainable funding system at all levels. Monitoring, evaluation and dissemination 
systems and plans or policies in the field of prevention practically do not exist in most of participating EU 
Member States.  Funding is mostly not available for outcome evaluation at all levels and is rarely related to 
monitoring and evaluation (both process and outcome).
 4.2.  
According to the feasibility study, this standard is reasonably well implemented by responding CSOs. Some 
CSOs have a long-term prevention plan in place for sustaining prevention activities. They often conduct 
monitoring and process evaluation, but rarely outcome evaluation. Most of them have dissemination 
system/plan in place.
 4.3.  
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• If you have a long term plan, explore the possibility of working with local, regional or national 
authorities to explore how such a plan might be supported into the future to ensure sustainability
• Given that CSOs operating in this area see themselves as having existing strength in implementing 
this standard, consider forming a network of CSOs who can work together on elements of monitoring, 
evaluation and dissemination 
• Work with a particular focus on outcome evaluation, as this is the area which CSOs currently self-report 
is weak. Explore with other stakeholders how outcome evaluation can best be supported to ensure 
coverage of target populations with effective prevention practices. 
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RISK AND HARM REDUCTION
STANDARD 5: RISK AND HARM REDUCTION MEASURES, INCLUDING BUT NOT LIMITED 
TO MEASURES RELATING TO INFECTIOUS DISEASES AND DRUG-RELATED DEATHS, ARE 
REALISTIC IN THEIR GOALS, ARE WIDELY ACCESSIBLE, AND ARE TAILORED TO THE NEEDS OF 
THE TARGET POPULATIONS.
 5.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Evidence-based interventions such as drug consumption rooms (DCRs) and naloxone distribution exist in 
very few countries, with the exception of opioid substitution treatment (OST). Improvements are needed 
concerning other interventions as well (e.g. gender specific interventions, voluntary counselling and BBV  
testing). Target populations are very rarely actively involved in intervention design, implementation and 
evaluation (both process and outcome).
 5.2. 
According to the feasibility study, this standard is also poorly implemented by participating CSOs. Most 
frequent evidence-based interventions are needle and syringe exchange programme and information, 
education and communication. The input of the target populations are very often assessed during all phases 
of intervention, with the exception of outcome evaluation.
 5.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Ensure that planned activities are meeting an identified need. It is critical that target populations are 
involved in all phases of the needs assessment, and in intervention design and evaluation.
• In the future, more focus should be oriented towards development and implementation of interventions 
such as drug consumption rooms (DCRs) and naloxone distribution, taking into account gender 
specific measures as well. Target populations should be more often included in intervention design, 
implementation and evaluation (both process and outcome).
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STANDARD 6: APPROPRIATE INTERVENTIONS, INFORMATION AND REFERRAL ARE OFFERED 
ACCORDING TO THE CHARACTERISTICS AND NEEDS OF THE SERVICE USERS, IRRESPECTIVE 
OF THEIR TREATMENT STATUS.
 6.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. In 
general, there is a reported lack of standardized comprehensive needs assessment at all levels (national, 
regional and local). Responses indicate a need to focus on linking RHR interventions to other interventions 
where appropriate, particularly those in the areas of social integration, rehabilitation and recovery services. 
Currently, the most focus is seen as being on links to medical and non-medical treatment. Consistent with 
other areas, service users do not seem to be well consulted in terms of engagement in needs assessment 
and service design. 
 6.2. 
According to the feasibility study, this standard is a bit better implemented by participating CSOs, except 
regarding the implementation of standardized comprehensive needs assessment, which rarely seems 
to be utilised in practice. Improvements are also needed concerning more consistent implementation 
of non-exclusion policies among CSOs. Some respondent CSOs offer or refer their service users to other 
interventions, especially non-medical treatment. They are also well connected with most of other services, 




For those CSOs interested in working on this standard, some things to consider are:
• Ensure that a comprehensive needs assessment is in place
• Explore working with services providing social integration, rehabilitation and recovery to see how you 
can work together to provide a seamless continuum of care of people using your services
• Ensure that an explicit, written non-exclusion policy is part of your own policy suite, as well as part of 
the suite of policies implemented by the other services you work with  
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STANDARD 7: INTERVENTIONS ARE AVAILABLE TO ALL IN NEED, INCLUDING IN HIGHER RISK 
SITUATIONS AND SETTINGS.
 7.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Interventions are rarely available to all in need; however, there is a bit better situation to some extent at 
local or regional levels. Higher risk situations are not very well addressed by RHR interventions (e.g. people 
who use drugs as victims of crime, people who use drugs in prisons). RHR services are very rarely provided in 
prison settings; however, improvements are needed also in other higher risk settings, such as open drug use 
scene, nightlife and festivals.
 7.2. 
 
According to the feasibility study, this standard is well implemented by participating CSOs as their 
interventions are mostly available to all in need.
 7.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Looking at your current service delivery and asking whether what you provide is available to all those 
who might need it and, if not, thinking about how you might work yourselves or in partnership to 
expand access, particularly in the context of higher risk settings. 
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STANDARD 8: INTERVENTIONS ARE BASED ON AVAILABLE SCIENTIFIC EVIDENCE AND 
EXPERIENCE AND PROVIDED BY QUALIFIED AND/OR TRAINED STAFF (INCLUDING 
VOLUNTEERS), WHO ENGAGE IN CONTINUING PROFESSIONAL DEVELOPMENT.
 8.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Interventions are rarely coherent with existing evidence-based criteria (such as that provided by EMCDDA) at 
all levels (national, regional and local). There is almost no formal education and/or training available in the 
field of RHR. Most of the professionals in this field have to rely on non-formal or informal education and/or 
training options, but improvements are needed in this area as well, including continuing education and/or 
training options to assure continuing professional development.
 8.2. 
According to the feasibility study, this standard is also poorly implemented by participating CSOs. Mostly 
they do not require formal education and/or training for their staff, including volunteers, and they are not 
often engaged in continuing education and/or training as well.
 8.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Explore options to work with national, regional or local authorities to work towards ensuring this 
standard is better implemented and that those who are committed to RHR work are trained and 
supported to do so. Given its status as a council conclusion, governments and authorities in EU Member 
States should be interested in exploring how work in this area can best be supported, for example by 
accrediting and recognising CSOs to work in the field of RHR and by providing support and sustainable 
funding for education and/or training, which could significantly improve competencies and expertise in 
this area of work.
• Before implementing or designing any RHR projects yourself, ensure that the staff who have been 
designated to carry out the work are properly supported and equipped, and have the competencies and 
expertise necessary to do the job. 
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TREATMENT, SOCIAL REINTEGRATION AND 
REHABILITATION (INCLUDING RECOVERY)
STANDARD 9: APPROPRIATE EVIDENCE-BASED TREATMENT IS TAILORED TO THE 
CHARACTERISTICS AND NEEDS OF SERVICE USERS AND IS RESPECTFUL OF THE INDIVIDUAL’S 
DIGNITY, RESPONSIBILITY AND PREPAREDNESS TO CHANGE.
 9.1. 
According to the assessment, this standard is rather well implemented in participating EU Member States. 
Service users are very well informed about different options of treatment programmes (e.g. long-term, 
short-term and outpatient treatment, individual counselling), and a bit less about some other options 
(e.g. group counselling and in-prison treatment and care). There is a lack of information on gender specific 
treatment programmes. Service users are rather often involved in treatment design, implementation and 
evaluation (except a bit less in outcome evaluation). Treatment providers mostly respect service users’ 
dignity, responsibility and preparedness to change; however, improvements are still needed concerning this 
part of the standard.
 9.2. 
According to the feasibility study, this standard is rather well implemented by participating CSOs. They 
provide different types of treatment for their service users, especially outpatient programmes, individual 
and group counselling. Improvements are needed especially regarding in-prison and gender specific 




For those CSOs interested in working on this standard, some things to consider are:
• Focusing on those aspects of the standard that are less well implemented, such as those oriented 
towards development and promotion of in-prison treatment and care, and treatment, which addresses 
gender specific needs.
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STANDARD 10: ACCESS TO TREATMENT IS AVAILABLE TO ALL IN NEED UPON REQUEST, AND 
NOT RESTRICTED BY PERSONAL OR SOCIAL CHARACTERISTICS AND CIRCUMSTANCES OR 
THE LACK OF FINANCIAL RESOURCES OF SERVICE USERS. TREATMENT IS PROVIDED IN A 
REASONABLE TIME AND IN THE CONTEXT OF CONTINUITY OF CARE.
 10.1. 
According to the assessment, this standard is very well implemented in participating EU Member States, 
except concerning the provision of treatment in reasonable time and to some extent the context of 
continuity of care as well. Improvements are needed concerning the availability of treatment to all in need, 
especially at national and regional levels. A non-exclusion policy is mostly operating, ensuring access 
regardless of the personal, social or financial situation of service users.
 10.2. 
According to the feasibility study, this standard is very well implemented by participating CSOs, including 
the provision of services in reasonable time and in the context of continuity of care. They mostly also have 
their own non-exclusion policy in place in relation to personal, social and financial situation of service users.
 10.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Focusing on those aspects of the standard that are less well implemented such as those oriented 
towards provision of treatment in reasonable time and the context of continuity of care, especially as a 
part of national, regional and/or local strategies and action plans.
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STANDARD 11: IN TREATMENT AND SOCIAL INTEGRATION INTERVENTIONS, GOALS ARE SET 
ON A STEP-BY-STEP BASIS AND PERIODICALLY REVIEWED, AND POSSIBLE RELAPSES ARE 
APPROPRIATELY MANAGED.
 11.1. 
According to the assessment, this standard is rather well implemented in participating EU Member States. 
However, improvements are needed concerning periodical review of the goals in treatment and social 
integration services. Improvements are also needed concerning the management of possible relapses in 
treatment and social integration interventions.
 11.2. 
According to the feasibility study, this standard is very well implemented by participating CSOs with no 
special concerns or challenges for improvements.
 11.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Focusing on those aspects of the standard that are less well implemented such as those oriented 
towards better periodical review of the goals at national and/or regional levels, and better management 
of possible relapses in treatment and social integration.
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STANDARD 12: TREATMENT AND SOCIAL INTEGRATION INTERVENTIONS AND SERVICES 
ARE BASED ON INFORMED CONSENT, ARE PATIENT-ORIENTED, AND SUPPORT PATIENTS’ 
EMPOWERMENT.
 12.1. 
According to the assessment, this standard is rather well implemented in participating EU Member States. 
However, improvements are needed concerning patient-oriented and patients’ empowerment approaches.
 12.2. 
According to the feasibility study, this standard is very well implemented by participating CSOs with no 
special concerns or challenges for improvements.
 12.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Review your current processes and programmes to ensure all your interventions and services are as  
patient-oriented as they can be
• Work with people who use your services to ensure that they are empowered to provide input and 
feedback on the services that will make a difference in their lives.
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STANDARD 13: TREATMENT IS PROVIDED BY QUALIFIED SPECIALISTS AND TRAINED STAFF 
WHO ENGAGE IN CONTINUING PROFESSIONAL DEVELOPMENT.
 13.1. 
According to the assessment, this standard is rather well implemented in participating EU Member States. 
However, improvements are needed concerning the development of specific job or profession-related 
qualification system at all levels and the provision of formal education and/or training and continuing (e.g. 
non-formal) education and/or training options for treatment professionals.
 13.2. 
According to the feasibility study, this standard is well implemented by participating CSOs. However, 
improvements are needed concerning the engagement of CSOs in continuing education and/or training of 
their staff at all levels.
 13.3. 
Recommendation(s): 
For those CSOs interested in working on this standard, some things to consider are:
• Explore options to work with local, regional and national authorities to further enhance education and 
training in this area, particularly in the context of ongoing professional development.
• Within your own organisation, ensure that all staff have their own personalised training plan, which is 
focused on enhancing their own professional development. 
• Work with partner agencies to explore non-formal training opportunities, such as staff swaps or agency 
placements. Such activities can both enhance individual skills, as well as improving organisational 
networking.
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STANDARD 14: TREATMENT INTERVENTIONS AND SERVICES ARE INTEGRATED WITHIN A 
CONTINUUM OF CARE TO INCLUDE, WHERE APPROPRIATE, SOCIAL SUPPORT SERVICES 
(EDUCATION, HOUSING, VOCATIONAL TRAINING, WELFARE) AIMED AT THE SOCIAL 
INTEGRATION OF THE PERSON.
 14.1. 
According to the assessment, this standard is rather well implemented in participating EU Member States. 
However, improvements are needed concerning information for service users about different services, 
especially social integration, rehabilitation and recovery, and supporting service users in education, 
housing, vocational training and welfare.
 14.2. 
According to the feasibility study, this standard is well implemented by participating CSOs. Their services 
are well integrated within a continuum of care model and aimed at the social integration of service users. 




For those CSOs interested in working on this standard, some things to consider are:
• As in other areas, there is scope to ensure links between services are a focus to ensure a seamless 
continuum of care for service users. In this instance, CSOs could consider linking with other 
stakeholders to better support access to ancillary services, such as education, housing, vocational 
training and welfare.
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STANDARD 15: TREATMENT SERVICES PROVIDE VOLUNTARY TESTING FOR BLOOD-BORNE 
INFECTIOUS DISEASES, COUNSELLING AGAINST RISKY BEHAVIOURS AND ASSISTANCE TO 
MANAGE ILLNESS.
 15.1. 
According to the assessment, this standard is rather well implemented in participating EU Member 
States. However, improvements are needed concerning the provision of voluntary testing for blood-borne 
infectious diseases, counselling against risky behaviour and assistance to manage illness at all levels.
 15.2. 
According to the feasibility study, this standard is very well implemented by participating CSOs with no 




For those CSOs interested in working on this standard, some things to consider are:
• Ensure access to voluntary testing for blood-borne infectious diseases and promote such services to 
people who could benefit from them.
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STANDARD 16: TREATMENT SERVICES ARE MONITORED AND ACTIVITIES AND OUTCOMES ARE 
SUBJECT TO REGULAR INTERNAL AND/OR EXTERNAL EVALUATION.
 16.1. 
According to the assessment, this standard is poorly implemented in participating EU Member States. 
Significant improvements are needed concerning the availability of funding for internal and external 
treatment outcome evaluation at all levels. Funding should be systematically related to monitoring and 
evaluation (both process and outcome). Improvements are needed as well concerning the development of 
monitoring system or plan, internal and external evaluation system or plan at all levels.
 16.2. 
According to the feasibility study, this standard is well implemented by participating CSOs. They regularly 




For those CSOs interested in working on this standard, some things to consider are:
• Explore options to work with local, regional and national authorities to enhance current approaches to 
systematic monitoring and evaluation (both process and outcome) of treatment services, in a manner 
that is consistent with such an approach being embedded in how services are delivered into the future. 
Within your own organisation, ensure that all your systems are oriented towards the evaluation of your 
service provision against good practice standards. 
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CONCLUSIONS
Drawing on the recommendations related to each specific standard, and on the feedback from the 
assessment and feasibility studies, there are a number of conclusions which are important to highlight. 
These are:
A) DISINVESTMENT FROM INEFFECTIVE AND HARMFUL INTERVENTIONS
Responses to the assessment and feasibility studies highlighted that there are still many interventions in 
the field of drug demand reduction, which are not being carried out in line with minimum quality standards. 
Governments and civil society organisations should be aware of this and consciously seek to disinvest and 
moving support away from ineffective services and interventions. Correspondingly, they should invest more 
resources towards implementation of evidence-based and effective interventions, especially in the fields of 
prevention and risk and harm reduction.
B) EDUCATION AND TRAINING & CONTINUING PROFESSIONAL DEVELOPMENT
The responses to the assessment and feasibility study pieces also reveal that there is a perceived gap in 
quality education and training for the drug demand reduction workforce (both in relation to basic training 
and in respect of continuing professional development). Governments and civil society organisations should 
investigate the long-term value of investment in this area, and look to invest more resources into developing 
and maintaining quality (formal and non-formal) education and training programmes for professionals and 
volunteers in the field of drug demand reduction.
C) MONITORING & EVALUATION 
According to the results of assessment and feasibility study, the evaluation culture is weak in Europe in the 
field of drug demand reduction. There is very little demand by (funding) authorities for monitoring and 
evaluation of programmes and other interventions (especially concerning outcome evaluation). Without 
evaluation there is impossible to say, which programmes and interventions are effective and has significant 
impact on the situation in the field of drug demand reduction. Governments and civil society organisations 
are advised to invest more in monitoring and evaluation, which would significantly improve the quality of 
interventions and motivation of professionals to continue with quality work.
However, those involved in monitoring and evaluation need to make sure of selecting the correct and 
adequate metrics and evaluation methods in order to avoid large box-ticking exercises, that may draw time 
away from the provision of services. Therefore, a balance should be established between the time needed to 
provide quality services and conducting efficient monitoring & evaluation.     
D) SUSTAINABLE FUNDING RELATED TO THE IMPLEMENTATION OF STANDARDS
According to the results of assessment and feasibility study, there is almost no sustainable funding for 
programmes and interventions in the field of drug demand reduction. States and funding bodies at all 
levels are advised to relate funding programmes and schemes to the implementation of minimum quality 
standards, but at the same time invest significantly more resources to improve the capacity of civil society 
organisations (technical and financial) to comply with those standards. Without sustainable funding, 
improved knowledge and skills of the workforce, and an improved monitoring and evaluation culture, we 
cannot expect significant improvements and developments in the field of drug demand reduction.
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